(Q33491075)

English

Phase I and pharmacokinetic studies of topotecan administered as a 72 or 120 h continuous infusion.

scientific article

Statements

Phase I and pharmacokinetic studies of topotecan administered as a 72 or 120 h continuous infusion (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit